Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens

The aim of this study was to identify the risk factors associated with severe bacterial infection (SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens. A total of 98 patients with MM were evaluated during 427 treatment courses. SBI occurred in 57.1% (56/98) of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Shin Young, Han, Sang Hoon, Kim, Soo-Jeong, Jang, Ji Eun, Kim, Yundeok, Cho, Hyunsoo, Lee, Jung Yeon, Cheong, June-Won, Min, Yoo Hong, Song, Jae-Woo, Kim, Jin Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810332/
https://www.ncbi.nlm.nih.gov/pubmed/27051233
http://dx.doi.org/10.3346/jkms.2016.31.4.510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810332/
https://www.ncbi.nlm.nih.gov/pubmed/27051233
http://dx.doi.org/10.3346/jkms.2016.31.4.510

Ejemplares similares